Literature DB >> 12144932

Endothelium-dependent production and liberation of kynurenic acid by rat aortic rings exposed to L-kynurenine.

Janusz Stazka1, Piotr Luchowski, Marian Wielosz, Zdzisław Kleinrok, Ewa M Urbańska.   

Abstract

Rat aortic slices produced and liberated the endogenous antagonist of glutamate receptors, kynurenic acid, upon exposure to L-kynurenine. Endothelium-denuded slices did not synthesize any measurable amount of kynurenic acid, indicating its endothelial origin. Aortic kynurenic acid production was diminished by modification of the ionic milieu, hypoxia and hypoglycemia, as well as by L-glutamate and L-aspartate, endogenous glutamate receptor agonists, and aminooxyacetic acid, a non-selective inhibitor of aminotransferases and mitochondrial respiration. These data pave the way for future research aimed to clarify the role of kynurenic acid in the physiology and pathology of the endothelium and vasculature. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12144932     DOI: 10.1016/s0014-2999(02)01943-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor.

Authors:  Katarzyna Wejksza; Wojciech Rzeski; Jolanta Parada-Turska; Barbara Zdzisinska; Robert Rejdak; Tomasz Kocki; Etsuo Okuno; Martyna Kandefer-Szerszen; Eberhart Zrenner; Waldemar A Turski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-10       Impact factor: 3.000

2.  Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions.

Authors:  Marita C Barth; Neil Ahluwalia; Thomas J T Anderson; Gregory J Hardy; Sumita Sinha; Jose A Alvarez-Cardona; Ivy E Pruitt; Eugene P Rhee; Richard A Colvin; Robert E Gerszten
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

3.  Kynurenic acid and its derivatives are able to modulate the adhesion and locomotion of brain endothelial cells.

Authors:  Eszter Lajkó; Bernadett Tuka; Ferenc Fülöp; István Krizbai; József Toldi; Kálmán Magyar; László Vécsei; László Kőhidai
Journal:  J Neural Transm (Vienna)       Date:  2018-01-13       Impact factor: 3.575

Review 4.  The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders.

Authors:  Trevor W Stone; L Gail Darlington
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 5.  Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.

Authors:  Qiongxin Wang; Danxia Liu; Ping Song; Ming-Hui Zou
Journal:  Front Biosci (Landmark Ed)       Date:  2015-06-01

6.  Effects of Kynurenic Acid on the Rat Aorta Ischemia-Reperfusion Model: Pharmacological Characterization and Proteomic Profiling.

Authors:  Viviane Soares Souza Lima; Douglas Oscar Ceolin Mariano; Hugo Vigerelli; Sabrina Cardoso Janussi; Thayz Vanalli Lima Baptista; Mário Angelo Claudino; Daniel Carvalho Pimenta; Juliana Mozer Sciani
Journal:  Molecules       Date:  2021-05-11       Impact factor: 4.411

7.  Changes in plasma kynurenic acid concentration in septic shock patients undergoing continuous veno-venous haemofiltration.

Authors:  Wojciech Dabrowski; Tomasz Kocki; Jacek Pilat; Jolanta Parada-Turska; Manu L N G Malbrain
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

Review 8.  Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions.

Authors:  Elisa Wirthgen; Andreas Hoeflich; Alexander Rebl; Juliane Günther
Journal:  Front Immunol       Date:  2018-01-10       Impact factor: 7.561

9.  Aortic stiffness-Is kynurenic acid a novel marker? Cross-sectional study in patients with persistent atrial fibrillation.

Authors:  Tomasz Zapolski; Anna Kamińska; Tomasz Kocki; Andrzej Wysokiński; Ewa M Urbanska
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

10.  Increased expression of kynurenine aminotransferases mRNA in lymphocytes of patients with inflammatory bowel disease.

Authors:  Ewa Dudzińska; Kinga Szymona; Renata Kloc; Paulina Gil-Kulik; Tomasz Kocki; Małgorzata Świstowska; Jacek Bogucki; Janusz Kocki; Ewa M Urbanska
Journal:  Therap Adv Gastroenterol       Date:  2019-10-19       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.